A necrotizing granuloma is a small, organized clump of immune cells with a dead (necrotic) core, formed when the body walls off something it cannot easily destroy. The necrotic center is what separates these from ordinary granulomas, and it signals a specific set of possible causes, most commonly tuberculosis, certain fungal infections, or autoimmune vasculitis. Figuring out which cause is responsible matters enormously, because treatment ranges from antibiotics to chemotherapy-strength immune suppression, and the imaging alone cannot tell the difference between a necrotizing granuloma and a malignant tumor.
What Makes a Granuloma “Necrotizing”
When your immune system encounters something it cannot quickly eliminate, macrophages, the immune cells that normally engulf and digest invaders, cluster together and recruit other immune cells to help. The result is a granuloma: a tiny, organized ball of cells that essentially quarantines the threat. In a non-necrotizing granuloma (the kind seen in sarcoidosis, for example), this cluster stays intact and the cells remain alive. In a necrotizing granuloma, the tissue at the center dies. Under a microscope, this dead zone often has a characteristic “cheesy” appearance pathologists call caseous necrosis, though the necrosis can also look more fibrinoid (waxy and protein-rich) depending on the underlying cause.
The necrosis itself is a byproduct of the immune battle. When the offending agent resists containment, the immune response intensifies: more inflammatory signals flood the area, and the tissue in the crossfire gets destroyed. The granuloma’s outer shell of immune cells serves as a barricade, keeping the threat from spreading while the interior essentially becomes a biological dead zone. This dynamic structure can persist for months or years, walling off a chronic infection or smoldering immune reaction.
Tuberculosis and Other Mycobacteria
Tuberculosis (TB) is the textbook cause of necrotizing granulomas, and for good reason. When Mycobacterium tuberculosis settles in the lungs, the immune system mounts a sustained attack, forming granulomas that contain the bacteria but often fail to kill them outright. Over time, the center of these granulomas dies. The bacterium has actually evolved to exploit this process: the necrotic granulomas can eventually erode into the airways, allowing infected material to be coughed up and spread to new hosts.1PubMed Central. The granuloma in tuberculosis: dynamics of a host-pathogen collusion
TB is not the only mycobacterium responsible. Non-tuberculous mycobacteria (NTM), a group of related organisms found in soil and water, also cause necrotizing granulomatous disease. In a study of pulmonary granulomatous lesions that were cultured for mycobacteria, about 65% grew M. tuberculosis, while roughly a third yielded NTM species such as M. avium, M. intracellulare, and M. kansasii.2PubMed Central. Incidence of mycobacteria in pulmonary granulomatous lesions Animal research has shown that certain strains of Mycobacterium avium complex (MAC) produce necrotizing granulomas that closely resemble those seen in TB, complete with infiltrating neutrophils, foamy macrophages, and a surrounding collagen capsule.3PubMed Central. Strain-dependent disease progression and necrotizing granuloma formation in a murine model induced by virulent strains of Mycobacterium avium complex The clinical takeaway is that finding a necrotizing granuloma does not automatically mean TB; the laboratory has to identify exactly which organism is present.
Fungal Infections That Trigger Necrotizing Granulomas
Several endemic fungi provoke the same type of granulomatous response. Histoplasmosis, caused by Histoplasma capsulatum and acquired by inhaling spores from contaminated soil (often enriched by bird or bat droppings), is one of the most recognized. Pulmonary histoplasmosis typically produces necrotizing granulomatous inflammation, and the resulting lung nodules can persist for years as calcified scars on imaging.4PubMed. Biopsy findings in acute pulmonary histoplasmosis: unusual histologic features in 4 cases mimicking lymphomatoid granulomatosis
Coccidioidomycosis, commonly known as Valley fever, follows a similar pattern. The soil fungus Coccidioides is inhaled when contaminated ground is disturbed, and granuloma formation is one of the immune system’s primary methods of attempting to contain it.5PubMed Central. Coccidioidomycosis Granulomas Informed by Other Diseases: Advancements, Gaps, and Challenges Other fungi known to cause necrotizing granulomas include Blastomyces and Cryptococcus. Geography matters here: histoplasmosis clusters in the Ohio and Mississippi River valleys, while coccidioidomycosis concentrates in the desert Southwest of the United States and parts of Central and South America. Knowing where a patient has lived or traveled is often the first clue pointing a clinician toward a fungal rather than mycobacterial cause.
Autoimmune and Vasculitic Causes
Not every necrotizing granuloma is driven by an infection. Granulomatosis with polyangiitis (GPA), formerly called Wegener’s granulomatosis, is a rare autoimmune vasculitis in which the immune system attacks small blood vessels, producing necrotizing granulomatous inflammation. It most commonly affects the upper airways, lungs, and kidneys. Biopsies typically show necrotizing granulomas clustered around damaged blood vessels, and blood tests are often positive for a specific autoantibody called c-ANCA (cytoplasmic antineutrophil cytoplasmic antibody), with elevated proteinase 3 (PR3) antibodies.6PubMed Central. Granulomatosis With Polyangiitis (GPA) Mimicking Metastatic Malignancy
Rheumatoid arthritis can also produce necrotizing granulomas, though with a different appearance. Rheumatoid nodules are palisading granulomas with central fibrinoid necrosis. They are a hallmark feature of rheumatoid arthritis and form part of the formal diagnostic criteria for the disease.7PubMed. Colocalization of C4d deposits/CD68+ macrophages in rheumatoid nodule and granuloma annulare: immunohistochemical evidence of a complement-mediated mechanism in fibrinoid necrosis These nodules usually appear in the skin, especially over pressure points like the elbows, but can occasionally show up in the lungs, complicating diagnosis when they are found on a chest scan without prior context.
Necrotizing granulomatous vasculitis can also occur in unusual locations. Reports have documented it in the gallbladder, where numerous necrotizing granulomas centered on blood vessels were found with acute and chronic inflammatory cells, including eosinophils, within zones of fibrinoid necrosis.8Journal of Surgery and Medicine. Necrotizing granulomatous vasculitis of the gallbladder. A case report Findings like these remind clinicians that necrotizing granulomas are not confined to the lungs.
Why Imaging Alone Cannot Tell You the Cause
One of the most clinically important facts about necrotizing granulomas is that on a CT scan, they can look identical to cancer. A study examining lung necrotizing granulomas on imaging found that their CT characteristics were indistinguishable from those of malignant tumors, making tissue biopsy essential for diagnosis.9PubMed. Necrotizing granuloma of the lung: imaging characteristics and imaging-guided diagnosis This is why so many necrotizing granulomas are found incidentally during surgery or biopsy for suspected cancer: a nodule or mass shows up on a scan, the patient undergoes a procedure, and the pathologist finds granulomatous inflammation rather than malignancy. For the patient, this is often a relief, though it opens a new diagnostic question about the cause of the granuloma itself.
The overlap with cancer is not just theoretical. GPA in particular has been reported to mimic metastatic malignancy, with multiple lung nodules and other masses prompting extensive cancer workups before the correct autoimmune diagnosis is reached.6PubMed Central. Granulomatosis With Polyangiitis (GPA) Mimicking Metastatic Malignancy This underscores why pathologists, microbiologists, and clinicians often need to collaborate closely when a biopsy reveals necrotizing granulomatous tissue.
The Diagnostic Workup
Once a biopsy confirms necrotizing granulomatous inflammation, the next step is determining the cause. The workup generally moves through several layers:
- Microbiology: Tissue samples are stained for acid-fast bacilli (to detect mycobacteria) and fungi, and sent for culture. Culture remains the gold standard for identifying the specific organism, but it can take weeks for mycobacteria to grow.
- PCR testing: When acid-fast stains and cultures come back negative but clinical suspicion remains high, polymerase chain reaction (PCR) testing on the tissue can detect mycobacterial DNA with high sensitivity. In one study, PCR identified mycobacteria in about 86% of biopsies that had been negative on traditional staining and culture, and follow-up confirmed TB in most of those patients.10PubMed. Rapid detection of mycobacteria in inflammatory necrotizing granulomas from formalin-fixed, paraffin-embedded tissue by PCR in clinically high-risk patients with acid-fast stain and culture-negative tissue biopsies
- Serological testing: For autoimmune causes like GPA, blood tests for ANCA antibodies are central. A positive c-ANCA with elevated PR3 antibodies strongly supports the diagnosis.
- Clinical context: Travel history, occupational exposures, immune status, and the pattern of organ involvement all guide the differential diagnosis.
Despite this toolkit, the cause remains unexplained in a substantial minority of cases. One review of necrotizing granulomatous inflammation in the liver noted that about 20% to 40% of cases go without an identified cause even after a thorough evaluation.11PubMed Central. Necrotizing granulomatous inflammation of the liver When all infectious and autoimmune tests come back negative, clinicians sometimes classify the granulomas as “idiopathic” and monitor the patient rather than committing to a treatment that might be unnecessary or misdirected.
When ANCA Tests Are Negative but GPA Is Still the Answer
One diagnostic pitfall deserves its own discussion. ANCA antibodies are a major clue pointing toward GPA, but roughly 10% to 20% of patients with GPA are ANCA-negative.12PubMed Central. ANCA-negative Granulomatosis with Polyangiitis: A Difficult Diagnosis This means that a normal ANCA result does not rule out the disease. The problem is particularly common in patients with localized GPA, where the disease is confined to the respiratory tract. In those cases, both the standard ANCA subtypes (MPO-ANCA and PR3-ANCA) are less likely to be positive.13Respiratory Medicine Case Reports. Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs When ANCA results are negative but biopsy shows necrotizing granulomatous vasculitis, clinicians have to weigh the tissue findings heavily rather than relying on the blood test alone.
A less common antibody, elastase-ANCA, can sometimes fill the gap, though it is positive in fewer than 1% of GPA cases and is not routinely measured.13Respiratory Medicine Case Reports. Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs The broader lesson is that the diagnosis of GPA often depends on fitting together clinical symptoms, imaging patterns, and biopsy results rather than relying on any single test.
Treatment Depends Entirely on the Cause
There is no single treatment for a necrotizing granuloma, because the granuloma itself is a response, not a disease. The treatment targets whatever provoked it.
For TB, standard multidrug antibiotic regimens lasting at least six months are the mainstay. NTM infections typically require prolonged courses of different antibiotic combinations, often lasting a year or more, and can be difficult to eradicate completely. Fungal infections like histoplasmosis may resolve on their own in mild cases, while more severe or disseminated disease requires antifungal therapy with agents like itraconazole or amphotericin B.
For autoimmune causes such as GPA, the standard first-line treatment for severe disease has been cyclophosphamide combined with glucocorticoids, which achieves sustained remission in roughly three out of four patients but carries serious side effects including increased infection risk, blood cell suppression, and infertility.14PubMed Central. Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis Rituximab, a monoclonal antibody that depletes B cells, has emerged as an alternative. Clinical trials demonstrated that rituximab was not inferior to cyclophosphamide-based therapy for inducing remission, and it has become a preferred option for patients who cannot tolerate cyclophosphamide or whose disease relapses.14PubMed Central. Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis Rituximab has also shown effectiveness in cases where conventional agents have failed.15The Open Respiratory Medicine Journal. Effectiveness of Rituximab in Severe Wegener’s Granulomatosis: Report of Two Cases and Review of the Literature
Rheumatoid nodules are generally managed by treating the underlying rheumatoid arthritis with disease-modifying agents rather than targeting the nodules directly. In some cases, paradoxically, methotrexate, a common rheumatoid arthritis drug, can make nodules worse.
Necrotizing Granulomas in Immunodeficient Patients
People with immune deficiencies represent a particularly challenging group. On one hand, they are more susceptible to the infections that cause necrotizing granulomas. On the other, their impaired immune systems can produce granulomatous reactions even without an identifiable infectious trigger, a paradox that makes diagnosis harder.
Common variable immunodeficiency (CVID), the most common symptomatic primary antibody deficiency, has been reported to present with necrotizing and sarcoid-like granulomas in the skin and joints as the first sign of the underlying immune disorder.16PubMed. Necrotizing and sarcoidal granulomas in the skin and synovial membrane, associated with common variable immunodeficiency Nijmegen breakage syndrome, a rare genetic disorder affecting DNA repair and causing combined immunodeficiency, has also been associated with chronic, treatment-resistant necrotizing granulomatous ulcers in children.17PubMed. Chronic noninfectious necrotizing granulomas in a child with Nijmegen breakage syndrome In these settings, the granulomas do not respond to antimicrobials because no pathogen is driving them, yet the underlying immune deficiency makes aggressive immunosuppression risky. Treatment often becomes a balancing act between managing the granulomatous inflammation and not further crippling an already weakened immune system.
Necrotizing Sarcoid Granulomatosis
A condition that blurs the line between several categories is necrotizing sarcoid granulomatosis (NSG). Its main features include sarcoid-like granulomas with both vasculitis and necrosis, typically presenting as multiple lung nodules without enlarged lymph nodes in the chest. Symptoms tend to be nonspecific: fever, chest pain, weight loss, cough, and shortness of breath. The imaging findings are varied enough to mimic infection, vasculitis, and malignancy. Despite this alarming presentation, NSG usually follows a benign clinical course and does not typically affect organs outside the lungs.18European Respiratory Review. Differential diagnosis of granulomatous lung disease: clues and pitfalls – Section: Necrotising sarcoid granulomatosis Whether NSG is truly its own disease or a variant of sarcoidosis remains debated among pathologists, but its generally favorable prognosis makes it an important entity to recognize so that patients are not overtreated based on a frightening-looking biopsy or scan.
Foreign Bodies and Environmental Exposures
Not every granuloma is triggered by an organism or an autoimmune process. Foreign body granulomas form when the immune system reacts to inorganic material it cannot digest: suture material, talc from injected drugs, silica dust, or even food particles that reach the wrong tissue. These granulomas can sometimes show necrosis, though their histologic pattern often looks distinct from the caseous necrosis of TB or the fibrinoid necrosis of vasculitis. The pathologist may spot the foreign material itself, often visible as birefringent (light-refracting) particles under polarized light, which clinches the diagnosis.
Occupational exposures, particularly inhaling metal fumes or mineral dust over long periods, can also produce granulomatous lung disease. Beryllium exposure, for example, causes chronic berylliosis, a granulomatous condition that closely mimics sarcoidosis on biopsy. These cases highlight the importance of a detailed occupational and exposure history in any patient with unexplained granulomatous inflammation. Granulomatous inflammation as a whole is caused by a wide range of conditions spanning infection, autoimmunity, toxic exposure, allergic reactions, drug reactions, and even neoplastic disease, making the pathologist’s job of narrowing the cause heavily reliant on clinical context.
Drug-Induced Granulomas
Certain medications can provoke granulomatous reactions that occasionally include necrosis. BCG (Bacillus Calmette-Guérin) therapy, used to treat bladder cancer, is a well-known example: it deliberately triggers a granulomatous immune response, which can sometimes extend beyond the bladder. Immunotherapy drugs used in cancer treatment, particularly checkpoint inhibitors, have also been linked to granulomatous inflammation in the lungs and other organs. Interferon therapy and certain anti-TNF biologic drugs used for autoimmune diseases have likewise been implicated. When a new lung nodule appears in a patient recently started on one of these drugs, drug-induced granulomatous disease belongs on the differential, though it remains a diagnosis of exclusion after infection and other causes are ruled out.